Research Focus: MEN-2B treatment outcomes and letrozole for delayed puberty
- PODCAST
- April 1, 2019
- Adrenal disorders, Puberty, Thyroid disorders
In our first edition, Professor Frederic Castinetti discussing the results of an international collaboration to study the natural history and treatment outcomes of multiple endocrine neoplasia type 2B, and Professor Martin Savage comments on a randomized trial of letrozole versus testosterone in boys with constitutional delay of growth and puberty.
Martin Savage
Programme Director
Sign up for eAlerts
Be the first to hear about new resources and content by signing up to receive our eAlerts.
Please provide your details:
